| P2093 | author name string | Y Xiao | |
| | N Han | |
| P2860 | cites work | Injection of Sca-1+/CD45+/CD31+ mouse bone mesenchymal stromal-like cells improves cardiac function in a mouse myocardial infarct model | Q47707893 |
| | [Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia]. | Q53706812 |
| | Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring | Q59713726 |
| | Intrinsic impairment of CD4(+)CD25(+) regulatory T cells in acquired aplastic anemia | Q84574717 |
| | Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study | Q85846346 |
| | A safety and feasibility study with platelet lysate expanded bone marrow mesenchymal stromal cells for the treatment of acute graft-versus-host disease in Brazil | Q87079341 |
| | Homing of chloromethylbenzoyl ammonia-labeled bone marrow mesenchymal stem cells in an immune-mediated bone marrow failure mouse model in vivo | Q87092413 |
| | The complex pathophysiology of acquired aplastic anaemia | Q28082135 |
| | Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 |
| | Graft failure in the modern era of allogeneic hematopoietic SCT. | Q33404733 |
| | Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation | Q33611550 |
| | Mesenchymal Stromal Cells Fail to Prevent Acute Graft-versus-Host Disease and Graft Rejection after Dog Leukocyte Antigen-Haploidentical Bone Marrow Transplantation | Q34520475 |
| | Mesenchymal stem cell as salvage treatment for refractory chronic GVHD | Q34562177 |
| | The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells | Q34704081 |
| | Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation | Q35599947 |
| | Lessons learned about human stem cell responses to ionizing radiation exposures: a long road still ahead of us. | Q37139081 |
| | In patients with chronic aplastic anemia, bone marrow-derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway | Q37640245 |
| | Immune tolerance and transplantation | Q38064621 |
| | Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine | Q38072473 |
| | Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment | Q38363548 |
| | Efficacy and safety of mesenchymal stromal cell treatment from related donors for patients with refractory aplastic anemia | Q38450575 |
| | Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results | Q39031953 |
| | Enhanced adipogenicity of bone marrow mesenchymal stem cells in aplastic anemia | Q39636102 |
| | Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Expanded In Vitro for Treatment of Aplastic Anemia: A Multicenter Phase II Trial | Q40057019 |
| | Clinical Observation of Haploidentical Hematopoietic Stem Cell Transplantation Combined with Bone-marrow Derived Mesenchymal Stem Cells Transfusion for Treatment of Children with Severe Aplastic Anemia | Q40086914 |
| | Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study. | Q40235917 |
| | Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells. | Q41121054 |
| | Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation | Q41707767 |
| | Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: enhance hematopoiesis after cord blood transplantation | Q43942762 |
| | Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy. | Q44578369 |
| | Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study | Q44718232 |
| | Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. | Q45866879 |
| | Innovative cell therapy in the treatment of serious adverse events related to both chemo-radiotherapy protocol and acute myeloid leukemia syndrome: the infusion of mesenchymal stem cells post-treatment reduces hematopoietic toxicity and promotes hem | Q45984550 |
| | Human Application of Ex-Vivo Expanded Umbilical Cord-Derived Mesenchymal Stem Cells: Enhance Hematopoiesis after Cord Blood Transplantation | Q46216214 |
| P433 | issue | 4 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 346-349 | |
| P577 | publication date | 2018-04-01 | |
| P1433 | published in | Chinese Journal of Hematology | Q27714364 |
| P1476 | title | [Research status and application prospect of mesenchymal stem cells in hematological diseases] | |
| P478 | volume | 39 | |